Drug dependence and prescribing ketamine for treatment-resistant depression in Australia and New Zealand

被引：0
|
作者：
Carroll, Alistair [1 ,2 ,14 ]
Bayes, Adam [1 ,2 ]
Montebello, Mark [3 ,4 ,5 ]
Brett, Jonathan [6 ,7 ,8 ,9 ]
Arunogiri, Shalini [10 ,11 ]
Saunders, John B. [12 ]
Loo, Colleen K. [1 ,2 ,13 ]
机构：
[1] Black Dog Inst, Neuromodulat & Intervent Psychiat, Sydney, NSW, Australia
[2] Univ New South Wales, Sch Clin Med Psychiat & Mental Hlth, Sydney, NSW, Australia
[3] Northern Sydney Local Hlth Dist, Drug & Alcohol Serv, St Leonards, NSW, Australia
[4] Univ Sydney, Specialty Addict Med, Camperdown, NSW, Australia
[5] Univ New South Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia
[6] St Vincents Hosp, Clin Pharmacol & Toxicol & Addict Med, Sydney, NSW, Australia
[7] Childrens Hosp Westmead, NSW Poisons Informat Ctr, Westmead, NSW, Australia
[8] Univ New South Wales, St Vincents Clin Sch, Sydney, NSW, Australia
[9] Univ New South Wales, Sch Populat Hlth, Med & Hlth Intelligence, Sydney, NSW, Australia
[10] Eastern Hlth, Turning Point, Statewide Addict & Mental Hlth Ctr, Melbourne, Vic, Australia
[11] Monash Univ, Monash Addict Res Ctr, Melbourne, Vic, Australia
[12] Univ Queensland, Natl Ctr Youth Subst Use Res, Brisbane, Qld, Australia
[13] George Inst Global Hlth, Cardiovasc Program, Sydney, NSW, Australia
[14] Black Dog Inst, Hosp Rd, Sydney, NSW 2031, Australia
来源：
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY | 2024年 / 58卷 / 10期
基金：
英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词：
Ketamine; drug dependence; depression; regulations; MENTAL-HEALTH; SELF-MEDICATION; OPIOID MISUSE; RISK-FACTORS; CHRONIC PAIN; ABUSE; ANTIDEPRESSANT; COMORBIDITY; DISORDERS; PREVALENCE;
D O I：
10.1177/00048674241242315
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
Ketamine is a restricted and regulated medication in Australia and New Zealand, which has implications when considering treatment for patients with treatment-resistant depression and a history of illicit drug use, abuse or dependence. Regulations governing prescription of ketamine for treatment-resistant depression vary between jurisdictions in Australia and New Zealand, though most restrict use in those with drug dependence. There is substantial variation in definitions of drug dependence used in each jurisdiction, and between the legal and clinical definitions, with the latter specified in the current International Classification of Diseases, Eleventh Revision and Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. This paper reviews the literature assessing the risk of ketamine misuse and dependence in patients with a history of illicit drug use, abuse or dependence and presents recommendations for psychiatrists who prescribe ketamine in such patients with treatment-resistant depression.
引用
收藏
页码：831 / 838
页数：8
相关论文
共 50 条
  • [31] Treatment-Resistant Depression: Program Development for Ketamine Infusion
    Miller, Courtney
    Bolton, Paula
    JOURNAL OF THE AMERICAN PSYCHIATRIC NURSES ASSOCIATION, 2019, 25 (04) : 332 - 332
  • [32] Use of Ketamine in Elderly Patients with Treatment-Resistant Depression
    Carolina Medeiros da Frota Ribeiro
    Patricio Riva-Posse
    Current Psychiatry Reports, 2017, 19
  • [33] Q/Is ketamine effective and safe for treatment-resistant depression?
    Zorn, Amanda
    Linn, Sean
    Jenkinson, Mat
    Neher, Jon O.
    Safranek, Sarah
    Kelsberg, Gary
    JOURNAL OF FAMILY PRACTICE, 2021, 70 (03): : E1 - E3
  • [34] KETAMINE FOR TREATMENT-RESISTANT DEPRESSION: READY FOR CLINICAL TRANSLATION?
    Loo, C. K.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2023, 57 (01): : 10 - 10
  • [35] Biological Perspectives Ketamine as an Alternative Treatment for Treatment-Resistant Depression
    Dowben, Jonathan S.
    Grant, Joan S.
    Keltner, Norman L.
    PERSPECTIVES IN PSYCHIATRIC CARE, 2013, 49 (01) : 2 - 4
  • [36] Efficacy of Ketamine in Treatment-Resistant Depression: An Umbrella Review
    Klassen, Amanda M.
    Baten, Caitlin
    Zamora, Gladys
    Shepherd, Jonah H.
    Johnson-Venegas, Ellie
    Madugula, Sasidhar S.
    Woo, Ellen
    Hamilton, J. Paul
    Miller, Jennifer A.
    Sacchet, Matthew D.
    Hedges, Dawson W.
    Miller, Chris H.
    BIOLOGICAL PSYCHIATRY, 2024, 95 (10) : S198 - S198
  • [37] Remission of Treatment-Resistant Depression With Electroconvulsive Therapy and Ketamine
    Niemegeers, Peter
    Schrijvers, Didier
    Madani, Yamina
    Sabbe, Bernard G. C.
    JOURNAL OF ECT, 2014, 30 (03) : E31 - E32
  • [38] The Downstaging Concept in Treatment-Resistant Depression: Spotlight on Ketamine
    Wilkowska, Alina
    Cubala, Wieslaw Jerzy
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (23)
  • [39] The Effect of Ketamine on Reinforcement Learning in Treatment-Resistant Depression
    Mkrtchian, Anahit
    Lally, Niall
    Nugent, Allison C.
    Evans, Jennifer W.
    Roiser, Jonathan P.
    Zarate, Carlos A.
    NEUROPSYCHOPHARMACOLOGY, 2019, 44 (SUPPL 1) : 456 - 457
  • [40] Ketamine for Treatment-Resistant Depression A Gateway to Novel Treatment Approaches
    Limandri, Barbara J.
    JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES, 2018, 56 (10) : 11 - 14
12345